Suchergebnisse - "Atagündüz, Pamir"

PubPharm (8)

1

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases : a non-systematic review

enthalten in: Clinical rheumatology | 2021

von Soy, M. | Keser, G. | Atagunduz, P. | +4

CommentIn: Clin Rheumatol. 2021 Jun;40(6):2517-2518. - PMID 33928459

2

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

enthalten in: Clinical rheumatology | 2021

von Soy, M. | Keser, G. | Atagunduz, P. | +4

3

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

enthalten in: Clinical rheumatology | 2021

von Soy, M. | Keser, G. | Atagunduz, P. | +4

4

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

enthalten in: Clinical rheumatology | 2021

von Soy, M. | Keser, G. | Atagunduz, P. | +4

5

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice : a single-centre experience

enthalten in: Clinical rheumatology | 2013

von Can, M. | Alibaz-Öner, F. | Yılmaz-Öner, S. | +3

6

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

enthalten in: Clinical rheumatology | 2012

von Can, M. | Alibaz-Öner, F. | Yılmaz-Öner, S. | +3

7

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

enthalten in: Clinical rheumatology | 2012

von Can, M. | Alibaz-Öner, F. | Yılmaz-Öner, S. | +3

8

Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience

enthalten in: Clinical rheumatology | 2012

von Can, M. | Alibaz-Öner, F. | Yılmaz-Öner, S. | +3

1
[1]